(Q36987260)

English

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop

scientific article published on 19 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop (English)

1 reference

Europe PubMed Central

17 August 2017

0 references

0 references

steatohepatitis

0 references

Food and Drug Administration

6

object named as

United States Food and Drug Administration

1 reference

Europe PubMed Central

17 August 2017

American Association for the Study of Liver Diseases

5

object named as

American Association for the Study of Liver Diseases

1 reference

Europe PubMed Central

17 August 2017

Lara Dimick-Santos

4

object named as

Lara Dimick-Santos

1 reference

Europe PubMed Central

17 August 2017

author name string

Arun J Sanyal

1

1 reference

Europe PubMed Central

17 August 2017

Scott L Friedman

2

1 reference

Europe PubMed Central

17 August 2017

Arthur J McCullough

3

1 reference

Europe PubMed Central

17 August 2017

language of work or name

0 references

publication date

19 March 2015

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

61

1 reference

Europe PubMed Central

17 August 2017

4

1 reference

Europe PubMed Central

17 August 2017

1392-1405

1 reference

Europe PubMed Central

17 August 2017

Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Quality of life in cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Prognostic indicators of survival in patients with compensated and decompensated cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Why does NAFLD predict type 2 diabetes?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Pediatric nonalcoholic fatty liver disease in 2009.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

The obesity epidemic and nonalcoholic fatty liver disease in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Assessment of prognosis of cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

When is a patient too well and when is a patient too sick for a liver transplant?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

The hepatic venous pressure gradient: anything worth doing should be done right

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Prevention of variceal rebleeding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Subacute liver failure in obese women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Factors associated with poor health-related quality of life of patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

A model to predict survival in patients with end-stage liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Portal venous pressure measurement and its clinical significance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

29 September 2017

Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

27 June 2018

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

27 June 2018

Prognosis in primary biliary cirrhosis: model for decision making

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

27 June 2018

Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

27 June 2018

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

27 June 2018

The global NAFLD epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Population-based risk factors and resource utilization for HCC: US perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Epidemiology of non-alcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Health-related quality of life in patients with non-alcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Depression, anxiety, and nonalcoholic steatohepatitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Histopathology of pediatric nonalcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Health-related quality of life in chronic liver disease: the impact of type and severity of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900161

4 September 2018

Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

NAFLD, NASH and liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Identification of farnesoid X receptor modulators by a fluorescence polarization-based interaction assay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Compensated cirrhosis: Natural history and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

21 January 2018

The survival benefit of liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of balloon vs. straight catheter for the measurement of portal hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of early measurements of portal pressure in acute variceal bleeding

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathology of nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplant recipients mortality on the waiting list: long-term comparison to Child-Pugh classification and MELD

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27678

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.27678

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36987260&oldid=1514410489"